Vertex Pharmaceuticals

Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Business Insider
Vertex Pharmaceuticals
Europe
EMA
CHMP
cystic fibrosis
Kalydeco
Kaftrio
Flag link:
CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment
CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment
Fierce Biotech
Vertex Pharmaceuticals
CRISPR Therapeutics
CTX001
gene editing
sickle cell disease
beta thalassemia
Flag link:
COVID-19 could cause surge in virtual trials, says Vertex expert
COVID-19 could cause surge in virtual trials, says Vertex expert
Pharmaforum
COVID-19
pandemic
clinical trials
virtual clinical trials
Vertex Pharmaceuticals
Flag link:
Derailed by the pandemic, FDA offers CRISPR, Vertex drug program VIP status for its comeback play
Derailed by the pandemic, FDA offers CRISPR, Vertex drug program VIP status for its comeback play
Endpoints
CRISPR Therapeutics
Vertex Pharmaceuticals
CTX001
pandemic
COVID-19
Flag link:
EMA gives thumbs up to key drugs from Novartis, Alexion, Vertex and more
EMA gives thumbs up to key drugs from Novartis, Alexion, Vertex and more
Endpoints
EMA
Europe
Novartis
Alexion
Vertex Pharmaceuticals
Flag link:
Vertex's cystic fibrosis drugs work, but they're too expensive, ICER finds
Vertex's cystic fibrosis drugs work, but they're too expensive, ICER finds
Endpoints
Vertex Pharmaceuticals
drug pricing
cystic fibrosis
ICER
Flag link:
Affinia secures $1.6bn worth deal from Vertex to develop AAV capsids for genetic therapies
Affinia secures $1.6bn worth deal from Vertex to develop AAV capsids for genetic therapies
Pharmaceutical Business Review
Affinia Therapeutics
R&D
Vertex Pharmaceuticals
virus capsids
gene therapy
Flag link:
Can Vertex (VRTX) Withstand the Coronavirus Impact on Q1 Earnings?
Can Vertex (VRTX) Withstand the Coronavirus Impact on Q1 Earnings?
Yahoo/Zacks.com
Vertex Pharmaceuticals
earnings
Flag link:
Vertex guns for virtual trials but hits pause, sees delays for 'some new study starts'
Vertex guns for virtual trials but hits pause, sees delays for 'some new study starts'
Fierce Biotech
Vertex Pharmaceuticals
COVID-19
clinical trials.
Flag link:
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Fierce Pharma
Vertex Pharmaceuticals
Alexion
Regeneron
GSK
earnings
Flag link:
Pharmacquired: Where are all the deals?
Pharmacquired: Where are all the deals?
BioPharma Dive
M&A
Gilead Sciences
Biogen
Sanofi
Eli Lilly
GSK
Merck
Vertex Pharmaceuticals
Flag link:
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
beta thalassemia
rare disease
drug development
Acceleron
Bristol-Myers Squibb
Bluebird Bio
Sangamo Therapeutics
Vertex Pharmaceuticals
Editas Medicine
Syros Pharmaceuticals
Flag link:
What's in Store for Vertex in 2020 After a Remarkable 2019?
What's in Store for Vertex in 2020 After a Remarkable 2019?
Yahoo/Zacks.com
Vertex Pharmaceuticals
cystic fibrosis
Orkambi
Kalydeco
Symdeko
Trikafta
Flag link:
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
Stat
biotech
Jeff Leiden
Vertex Pharmaceuticals
Herb Boyer
Bob Swanson
Genentech
Amgen
George Rathmann
Gordon Binder
Flag link:
Vertex drops VX-961 to continue search for perfect pain drug
Vertex drops VX-961 to continue search for perfect pain drug
Fierce Biotech
Vertex Pharmaceuticals
VX-961
painkillers
Flag link:
Vertex impresses with strong Trikafta launch
Vertex impresses with strong Trikafta launch
BioPharma Dive
Vertex Pharmaceuticals
drug launches
cystic fibrosis
Trikafta
earnings
Flag link:
Are Biotech Stocks Due for a Correction in 2020?
Are Biotech Stocks Due for a Correction in 2020?
Motley Fool
biotech stocks
Axsome Therapeutics
Seattle Genetics
Vertex Pharmaceuticals
Flag link:
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
Endpoints
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2020
Gilead Sciences
M&A
Flag link:
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
Flag link:
The 4 biggest pharma market access stories of 2019
The 4 biggest pharma market access stories of 2019
Pharmaforum
biosimilars
UK
Orkambi
Vertex Pharmaceuticals
drug pricing
FDA
NICE
Flag link:

Pages